Novel approach could limit common complications of immunotherapy – Medical Xpress
Novel approach could limit common complications of immunotherapyMedical XpressBy connecting highly effective cancer immunotherapy drugs such as anti-CTLA4 (ipilimumab) and anti-PD-L1 (atezolizumab) to peptides that bind to tissues in and around tumors,… Continue reading
